SOAT1 and prostate cancer: Overall, chromatin‐based epigenetic modifications are key drivers of metastatic prostate cancer, contributing to aggressive phenotypes by promoting JAK–STAT signaling and EMT, as well as enabling cancer cells to adopt immune‐like characteristics.